Topical treatment of psoriasis with dithranol.
D000287:Administration, Topical; D000873:Anthracenes / Q000008:administration & dosage*; D000875:Anthralin / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D014467:Ultraviolet Therapy
D000873:Anthracenes; D000875:Anthralin